80020 (80020) Fair Value & Analysis
· Market cap HK$81.3B
Fair value as of: Jul 2, 2026
From 1 valuation models · updated today
Share price −28.0% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$1.11 – HK$2.65 · fair‑value band HK$0.4700 – HK$0.8600 · the HK$1.13 price screens above the HK$0.7100 fair value. As of Jul 2, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
80020 (80020) currently trades at HK$1.13, while our model-based Fair Value estimate is HK$0.7100 — implying the stock looks roughly 37.2% overvalued today. We read business quality at 39/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, 80020 generated revenue of HK$5.0B at a net margin of -35.2%. Revenue grew 30.7% year over year. It earns a return on equity of -7.0%. Fundamentals as of Jul 2, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
80020 reported revenue of HK$5.0B in FY2025 versus HK$3.8B in FY2022, a compound +9.6%/yr. Reported net income was −HK$1.8B in FY2025.
Is 80020 fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is 80020 (80020) undervalued?
What is the fair value of 80020?
What is the quality score of 80020?
What is the revenue of 80020 (80020)?
What is the net profit margin of 80020?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.